002826.SZ

Tibet AIM Pharm. Inc. [002826.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002826.SZ Stock Summary

Top 10 Correlated ETFs

002826.SZ

Top 10 Correlated Stocks

002826.SZ

In the News

002826.SZ Financial details

Company Rating
-
Market Cap
1.61B
Income
46.78M
Revenue
803.27M
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
0.86%
Employees
447
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
49.29
Forward P/E
-
PEG
42.86
P/S
2.76
P/B
3.06
P/C
-
P/FCF
29.43
Quick Ratio
2.15
Current Ratio
2.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.25
EPS next Y
-
EPS next Q
-
EPS this Y
4.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.09%
Revenue last 5Y
11.88%
Revenue Q/Q
-21.04%
EPS Q/Q
71.33%
-
-
-
-
SMA20
-16.67%
SMA50
5.26%
SMA100
100%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.07%
Gross Margin
47%
Oper. Margin
7%
Profit Margin
6%
Payout
44%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.57-13.28
52W High
+59.85%
52W Low
+315.6%
RSI
44
Rel Volume
2.86
Avg Volume
6.61M
Volume
18.9M
Perf Week
8.12%
Perf Month
-2.17%
Perf Quarter
88.05%
Perf Half Y
86.7%
-
-
-
-
Beta
0.312
-
-
Volatility
0.47%, 1.85%
Prev Close
7.06%
Price
20.78
Change
6.67%

002826.SZ Financial Performance

002826.SZ Dividend History

002826.SZ Frequently Asked Questions

What is Tibet AIM Pharm. Inc. stock symbol ?

Tibet AIM Pharm. Inc. is a CN stock and trading under the symbol 002826.SZ

What is Tibet AIM Pharm. Inc. stock quote today ?

Tibet AIM Pharm. Inc. stock price is $20.78 today.

Is Tibet AIM Pharm. Inc. stock public?

Yes, Tibet AIM Pharm. Inc. is a publicly traded company.

Something similar

Top by Market Cap
MIX.JO
FB2A.DE
BRK-A
0YXG.L
NVDA
Top Correlated ETFs
EGV1.DE
EXH5.DE
SC0Y.DE
LIRU.DE
INS.PA
Top Correlated Stocks
TNE5.DE
1995.HK
TEF.MC
002860.SZ
0728.HK
Similar Market Cap
CNNE
PTGX
2033.TW
KAPE.L
003002.SZ

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 6.61M
  • Market Capitalization 1.61B
  • Employee 447
  • CEO Mr. Ke Xu
  • Headquarters Beijing,CN
  • IPO Date 2016-12-12
  • Website https://www.emyy.cn

Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.